News | Published:

Scarred by disease

Nature Medicine volume 17, pages 1820 (2011) | Download Citation

  • A Correction to this article was published on 04 February 2011

This article has been updated

Collagen may be the darling of the beauty world for its purported antiwrinkle function, but too much of the protein can have ugly—even deadly—consequences. Measuring and treating this overabundance, known as fibrosis, presents a seemingly impossible challenge. Thomas Hayden visits a company in California offering a weighty solution.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 18 January 2011

     In the January 2011 issue of Nature Medicine, the article entitled “Scarred by disease” (Nat. Med. 17, 18–20, 2011) stated that the STX-100 compound from Stromedix is a small-molecule drug. However, the drug is actually a monoclonal antibody. The error has been corrected in the HTML and PDF versions of the article.

Author information


  1. Thomas Hayden is a San Francisco–based science writer.

    • Thomas Hayden


  1. Search for Thomas Hayden in:

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing